OICHARTS
8 AMThe 8 AM report →

ABVC

ABVC BioPharma, Inc. Common Stock · XNAS · 131 sessions on record
$1.06▲ +0.02 · +1.9%from $1.04 the session before · Sep 30, 2026 close · end of day
Open
$1.06
High
$1.09
Low
$1.04
Day's range
$0.054.5% of the previous close
VWAP
$1.05close +0.48% from it
Volume, shares
55.2K0.39× the 20-session average
Traded, $
$58.2K
Trades
353160 shares per trade
Previous close
$1.04+0.02 to the close
Market cap
$28.3Mat the close of Sep 30
Day range43% of the way up
$1.04$1.09
52-week range24% of the way up
$0.71 Aug 26$2.15 Jul 7

−51% from the high · +50% from the low

Options

No listed options on ABVC

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
ABVC close over the last 126 sessions, with S&P 500 rebased to the first close0.711.362.02axis spans 186%S&P 500ABVCApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 186 percent.

Quarterly results

consolidated · latest filed Aug 12, 2026 · SEC filings

Profit −$736.9K in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of ABVC on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Aug 12——−$736.9K—-0.03▼ −0.1%S&P 500 +0.7% · −0.8 pp
Mar 2026filed May 18——−$1.6M—-0.06▲ +2.8%S&P 500 −0.7% · +3.5 pp
Dec 2025filed Mar 3——−$2.8M—-0.11—not reached
Sep 2025filed Mar 3$796.0K▲ +100%−$2.0M—-0.09—not reached
Jun 2025filed Aug 12——−$2.3M—-0.13▼ −0.1%S&P 500 +0.7% · −0.8 pp
Mar 2025filed May 18——−$842.1K—-0.06▲ +2.8%S&P 500 −0.7% · +3.5 pp
Dec 2024filed Apr 15$2.0K▼ −9.2%−$731.6K—-0.02—not reached
Sep 2024filed Mar 3$389.3K▲ +2,400%−$394.8K—-0.03—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of ABVC on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025——−$7.9M—-0.39
FY24to Dec 2024$509.6K▲ +230%−$4.9M—-0.42
FY23to Dec 2023$152.4K▼ −84%−$7.8M—-1.80
FY22to Dec 2022$969.8K▲ +170%−$16.4M—-5.19
FY21to Dec 2021$355.8K▼ −26%−$12.8M—-0.51

Fundamentals

consolidated · filings to Jun 2026 · close $1.06 on Sep 30

2.8 times book value, market cap $28.3M.

Valuation
Market cap
$28.3Mon Sep 30
Price to earnings
—
Trailing EPS
$-0.29diluted · consolidated · four quarters to Jun 2026
Price to book
2.8consolidated · balance sheet to Jun 2026
Book value a share
$0.39consolidated · balance sheet to Jun 2026
Debt to equity
—
Return on equity
-82%trailing profit over average equity · consolidated
Dividend yield
—
Price to sales
—
Shares outstanding
26.7Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—
Revenue growth, 12 months
—
Revenue 3-year CAGR
—trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
−$7.1Mfour quarters to Jun 2026
Profit growth, 12 months
—
Profit 3-year CAGR
—

Corporate actions

exchange records

No corporate action on record for ABVC yet.

Price history

131 sessions on record · to Sep 30 · end of day

ABVC is +28.4% over 20 sessions against the S&P 500's +0.1%, 51% below its 52-week high, realised volatility 88% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $ABVC %S&P 500 %Difference pp
120 sessionssince Apr 9$1.43▼ −26%▲ +12%−38
60 sessionssince Jul 7$2.02▼ −48%▲ +2.0%−50
20 sessionssince Sep 1$0.83▲ +28%▲ +0.11%+28
5 sessionssince Sep 23$1.14▼ −7.0%▼ −0.67%−6.3
1 sessionsince Sep 29$1.04▲ +1.9%▼ −0.21%+2.1
Averages of the closeclose against each average
5-session average
$1.07close −0.93% from it
20-session average
$1.05close +0.95% from it
50-session average
$1.00close +6.0% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$0.098.3% of the close
Average day's range, 20
$0.109.3% of the close
Volume against 20 sessions
0.39×55.2K vs 140K average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
88%≈ ±5.5% a session · moved more than that on 6 of 20
Realised volatility, 60
110%≈ ±6.9% a session · moved more than that on 12 of 60
Beta to S&P 500, 60
1.72moved with S&P 500 on 31 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
13 up · 7 downof 20
Last 60 sessions
28 up · 29 downof 57
Best session, 250
▲ +28%Apr 6
Worst session, 250
▼ −28%Jul 9

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 4.9% of reported volume on Sep 30, 2026, against 47% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
ABVC daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 20261.36K27.7K4.9%
Sep 29, 202611.9K68.3K17.5%
Sep 28, 20261.62K31K5.2%
Sep 25, 202619.2K51.6K37.1%
Sep 24, 20268.52K38.1K22.3%
Sep 23, 202623.7K45.7K51.9%
Sep 22, 202626.2K45.9K57.2%
Sep 21, 202658.1K105K55.6%
Sep 18, 202655.6K88.1K63.1%
Sep 17, 202627.5K166K16.6%

Filings

SEC EDGAR · newest first
ABVC SEC filings
FiledFormReport date
Sep 11, 2026PRER14A—
Aug 27, 20268-KAug 27, 2026
Aug 25, 2026PRER14A—
Aug 17, 2026424B4—
Aug 17, 2026424B4—
Aug 17, 2026424B4—
Aug 17, 2026424B4—
Aug 12, 2026PRER14A—
Aug 12, 202610-QJun 30, 2026
Aug 12, 20268-K/AAug 3, 2026
Aug 4, 20268-KAug 3, 2026
Jul 28, 2026PRE 14AJul 28, 2026
Jul 2, 20268-KJul 2, 2026
May 18, 202610-QMar 31, 2026
May 15, 2026NT 10-QMar 31, 2026
Mar 27, 2026POS AM—
Mar 27, 20268-KMar 27, 2026
Mar 5, 2026DEF 14AMar 26, 2026
Mar 3, 202610-KDec 31, 2025
Mar 3, 202610-Q/ASep 30, 2025
Mar 3, 20268-KMar 3, 2026
Feb 5, 2026PRE 14AFeb 5, 2026
Jan 16, 20268-K/AApr 30, 2025
Nov 14, 2025424B4—
Nov 14, 2025424B4—

About ABVC BioPharma, Inc. Common Stock

SEC and exchange records
Company
ABVC BioPharma, Inc. Common Stock
Exchange
XNAS
SEC CIK
1173313
Sessions on record
131
Price source
End of day · delayed
Computed
2 Oct, 02:27 am IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.